Bone Marrow TransplantationHepatic Veno-Occlusive DiseaseTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationAnemia, AplasticLeukemiaTransplantation ConditioningHematopoietic Stem Cell TransplantationBone MarrowBone Marrow CellsTransplantation, AutologousT-LymphocytesMice, Inbred C57BLHematopoietic Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone and BonesTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityTransplantation, IsogeneicImmunosuppressionCyclophosphamideBone Marrow DiseasesHematopoiesisKidney TransplantationTime FactorsRadiation ChimeraRecurrenceCombined Modality TherapyLeukemia, Myeloid, AcuteBone Marrow ExaminationHematologic NeoplasmsImmunosuppressive AgentsTreatment OutcomeRemission InductionGraft RejectionRetrospective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsLymphocyte DepletionGraft vs Host ReactionLeukemia, MyeloidStem Cell TransplantationSevere Combined ImmunodeficiencyLeukocyte TransfusionLymphoma, Non-HodgkinAcute DiseaseHeart TransplantationColony-Forming Units AssayChimeraHLA AntigensSurvival AnalysisMyelodysplastic SyndromesPostoperative ComplicationsLung TransplantationLymphocyte TransfusionHematologic DiseasesCyclosporineActuarial AnalysisBone DensityAntineoplastic Combined Chemotherapy ProtocolsCell DifferentiationNuclear FamilyCarmustinePancytopeniaGraft vs Tumor EffectOrgan TransplantationGraft vs Leukemia EffectCytomegalovirus InfectionsLeukocyte CountFollow-Up StudiesSpleenCytarabineSurvival RateMice, Inbred BALB CGranulocyte Colony-Stimulating FactorFlow CytometryMelphalanBone ResorptionDisease-Free SurvivalEtoposideCells, CulturedLymphomaMultiple MyelomaMice, KnockoutAntigens, CD34Thymus GlandFatal OutcomeCord Blood Stem Cell TransplantationCell TransplantationHodgkin DiseaseInfection